A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women

Blood

Volumn 90, Issue 5, 1997, Pages 1747-1750

  Rosendaal, F R ^a   Siscovick, D S ^b   Schwartz, S M ^b   Psaty, B M ^b   Raghunathan, T E ^b   Vos, H L ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ATHEROGENESIS; CORONARY RISK; EFFECTOR CELL; FEMALE; GENE MUTATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL; THROMBOSIS;

EID: 0030921663     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.5.1747     Document Type: Article

References (23)

1. Jackson CM: Physiology and biochemistry of prothrombin, in Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds): Haemostasis and Thrombosis. Edinburgh, UK, Churchill Livingstone, 1994, p 397
2. Bertina RM, van Tilburg NH, de Fouw NJ, Haverkate F: Thrombin, a link between coagulation activation and fibrinolysis. Ann NY Acad Sci 667:239, 1992
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698, 1996
4. Degen SJ, Davie EW: Nucleotide sequence of the gene for human prothrombin. Biochemistry 26:6165, 1987
5. Doggen CJM, Visser T, Bertina RM, Manger Cats V, Rosendaal FR: Prothrombin 20210 G > A as a moderate risk factor for myocardial infarction. Thromb Haemost 77:379, 1997 (abstr, suppl)
6. Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004, 1993
7. Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
8. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr, Raghunathan TE, Koepsell TD, Reitsma PH: Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 89:2750, 1997
9. Uhl GS, Farrell PW: Myocardial infarction in young adults: Risk factors and natural history. Am Heart J 105:548, 1983
10. Zimmerman FH, Cameron A, Fisher LD, Ng G: Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 26:654, 1995
11. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, Psaty BM, Longstreth WT Jr, Koepsell TD, Raghunathan TE, Reitsma PH: Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 96:412, 1997
12. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty BM, Rautaharju P, Tracy RP, Weiler PG, for the Cardiovascular Health Study Research Group (CHS): The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1:263, 1991
13. Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J: Random digit dialing in selecting a population-based control group. Am J Epidemiol 120:825, 1984
14. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
15. Glisic S, Alavantic D: A simple PCR method for detection of defined point mutations. Trends Genet 12:391, 1996
16. Sidney S, Petitti DB, Quesenberry CP, Jr., Klatsky AL, Ziel HK, Wolf S: Myocardial infarction in users of low-dose oral contraceptives. Obstet Gynecol 88:939, 1996
17. Rosendaal FR: Thrombosis in the young: epidemiology and risk factors, a focus on venous thrombosis. Thromb Haemost 78:1, 1997
18. Siscovick DS, Schwartz SM, Rosendaal FR, Psaty BM: Thrombosis in the young: Effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors. Thromb Haemost 78:7, 1997
19. Kanitz MG, Giovannucci SJ, Jones JS, Mott M: Myocardial infarction in young adults: Risk factors and clinical features. J Emerg Med 14:139, 1996
20. McKenna WJ, Chew CY, Oakley CM: Myocardial infarction with normal coronary angiogram. Possible mechanism of smoking risk in coronary artery disease. Br Heart J 43:493, 1980
21. Rees DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet 346:1133, 1995
22. Cox MJ, Rees DC, Martinson JJ, Clegg JB: Evidence for a single origin of factor V Leiden. Br J Haematol 92:1022, 1996
23. Bergstrand R, Vedin A, Wilhelmsson C, Wallin J, Wedel H, Wilhelmsen L: Myocardial infarction among men below age 40. Br Heart J 40:783, 1978